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Abstract  
Introduction: Since the endorsement of GeneXpert MTB/RIF by the WHO, many countries have embarked on implementing this 
technology. Objective: We outline the cost of installing GeneXpert in district hospitals in Abuja, Nigeria. Methods: We prospectively documented 
costs related to the installation of GeneXpert at five sites. Costs were collected from receipts received from suppliers and normalized to USD 2012 
values. Results: Costs were often identified after initiating installation for many reasons. Installation varied widely between sites with sufficient 
space and power supply; sites with insufficient space or power supply and costs not directly associated with site installation. The basic cost for 
installation was USD 2,621.98 per machine. Sites that required additional space cost close to USD 7,000.00. Conclusion: Space and power 
requirements have a significant effect on installation costs. Countries need to carefully consider the placement of Xpert machines based on the 
quality and size of the available infrastructure. 
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Introduction 
 
Since the World Health Organization WHO endorsement of Xpert 
MTB/RIF in December 2010 and its subsequent recommendation to 
health authorities to roll-out the technology in phases within the 
context of national plans, many high Tuberculosis (TB) burden 
countries have embarked on implementing the technology to 
improve the management of TB [1]. Xpert allows a rapid diagnosis 
of TB and a presumptive diagnosis of multi drug resistant TB (MDR 
TB) without requiring the comparatively sophisticated laboratory 
facilities and complex methodologies of other established tests such 
as culture and line probe assays. 
  
In addition to the capital equipment expenditure and recurrent costs 
for the cartridges and calibrating machines [2], there are costs 
associated with upgrading laboratories to receive the new Xpert 
MTB/RIF machines. These costs are likely to be inversely 
proportional to the strength of the laboratory infrastructure and to 
vary across locations [3]. This information however is critical when 
an institution is planning the introduction of Xpert, and an estimate 
of the likely costs will inform scale-up decisions. While there are 
large numbers of studies on the accuracy of Xpert, there is no 
literature describing the costs associated with its installation in 
resource -limited settings [4]. 
  
WHO in its 2012 global TB report ranked Nigeria as the country with 
the 10th highest burden of TB with characteristics of a low resource 
setting [5]. The Federal Capital Territory (FCT) TB and Leprosy 
Control Programme (TBLCP) was established in 1992 and currently 
provides 39 treatment and 22 diagnostic centers. In 2012 it 
diagnosed 2111 patients but, despite a rapid expansion since 
inception, the case detection rate is still low (at 58%) and below the 
Nigerian target of 70%. In 2010, the FCT TBLCP purchased 5 new 
Xpert machines as part of a programme to increase case detection. 
The study presented the opportunity to describe the costs 
associated with the introduction of Xpert in selected district 
hospitals within this context. 
  
  
Methods 
 
Five four-module Xpert instruments were received by the FCT-
TBLCP in January 2012 and installed from April to July 2012 in 
district hospitals of the Local Area Councils (LAC) of the FCT. The 
equipment was part of a TB-REACH-funded project (STOP TB 
Partnership, Geneva) to test a new approach to increase TB case 
detection amongst adults in the FCT and the hospital selected had 
to be located outside Abuja's metropolitan area. The equipment was 
purchased at the Foundation for Innovative New Diagnostic (FIND) 
price of 17,500 USD per instrument, computer and freight on board. 
The project developed a network of community health extension 
workers who conducted house-to-house visits to identify adults with 
symptoms of TB and motorbike riders who linked the teams to the 
laboratory facilities by transporting specimens. Patients were tested 
using smear-microscopy and smear-negative patients were further 
tested with Xpert using an interim diagnostic algorithm. The 
management of the patients was conducted by the programme 
using its treatment algorithms [6]. 
  
During its planning phase, the project assessed the LAC hospital 
laboratories that routinely conducted smear microscopy to select 
those considered to have suitable facilities for the introduction of 
Xpert. Assessments were conducted by a team of laboratory staff, 
doctors and programme managers working with the Federal Ministry 
of Health, the FCT TBLCP and Zankli Medical Centre, a private TB 
research laboratory which supports the NTBLCP and acts as a 
reference diagnostic centre for the programme. The assessments 
documented the availability of space to accommodate the 
instrument and accessories, including a portable computer and bar 
reading stand, bench space, a backup system for electricity and the 
security of the premises. Laboratories also had to have at least two 
laboratory staff were willing to participate who had basic computer 
literacy for data entry, processing and printing of results. 
  
The costs incurred from the installation were prospectively 
documented. Costs were documented from receipts received from 
registered suppliers and normalized to United States Dollar (USD) 
2012 values by using the mean exchange rate across the year (USD 
1 = 156 Nigerian Naira). Costs were stratified in three categories: - 
Cost incurred to install the machines for laboratories with sufficient 
space and adequate electricity supply. These costs were considered 
the basic expense required for installation and were the same for all 
five laboratories. - Costs not directly associated with site 
infrastructure, including custom clearance and training. - Costs 
incurred into sites subsequently considered having inadequate 
electricity supply or insufficient space to accommodate additional 
equipment needs identified during the installation. Recurrent costs 
for running and maintaining the instruments are not included (e.g. 
maintenance and fuel for generators and module calibrations). 
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School of Tropical Medicine United Kingdom. 
  
  
Results 
 
A wide range of costs were incurred during the installation of the 
instruments. Some of these problems were not foreseen before 
initiating the project and costs often snowballed due to variety of 
reasons. For example, despite the survey, it was soon recognized 
that the electricity backup system provided by the hospitals still 
allowed short electricity interruptions before a generator re-instated 
the supply. In turn, the extra equipment needed to secure 
uninterrupted electrical supply required additional laboratory space. 
  
The main basic costs incurred to install the machines in the 
laboratories are described in Table 1. These included minimal 
upgrade of the laboratory premises, painting and reinforcement of 
working benches, minimal plumbing, additional chairs, extension 
cables and sockets, voltage stabilizers, inverters and truck batteries, 
a printer and a refrigerator. Computers required antivirus software 
and equipment was engraved and secured with cables to prevent 
thefts. Additional bench space for the equipment and processing of 
specimens was required by staff in all sites. Custom clearance 
required payment of a handler despite being duty free and transport 
to the facilities. The total of these costs amounted to USD 2621.98 
per laboratory. 
  
In two laboratories we purchased generators because the hospitals' 
own generators were broken. The electrical equipment (invertors, 
batteries etc) was bulky and required more space than anticipated 
and was not possible to accommodate them within the laboratory 
premises. It became evident that the added equipment 
overwhelmed the laboratory and could not be accommodated into 
the existing premises. 
  
We therefore purchased and furnished cargo containers to provide 
additional bench, storage and office space. Refurbishment included 
air conditioners, as temperatures are usually >30oC. The costs for 
the sites requiring additional premises are shown inTable 2. These 
additional costs ranged from $2,621.98 to $9,716.21. 
  
  
Discussion 
 
The WHO technical and operational guidance on Xpert [2] provides 
annual itemized budget calculations [4] based on the instrument 
selected. District hospitals in Nigeria however have multi-purpose 
diagnostic laboratories where space is at a premium and have 
limited resilience to adapt to receive new technologies. The 
guidance costs of installing the Xpert instrument differs from the 
costs we experienced in this project. For example, the costs of 
securing an uninterruptable supply of power were three times 
higher (USD 1666.86) than estimated in the guidance (USD 500). 
Although services are supposed to have a minimal of equipment, 
this is often in poor condition. Despite the laboratories indicating 
they had the minimum equipment needed, we had to purchase 
capital items such as refrigerators, air conditioners and in two cases 
generators to allow Xpert services to function. Even without 
generators the costs of installing the machines was USD 1,921.99 
per site, which is considerably more expensive that the guidance 
estimates. Conversely, the cost of training was lower in our case 
(USD 2,605.19), than the guidance estimate of USD 5,000, which 
was due to the availability of in-house expertise for installation and 
training. 
  
Finding the space required for the machines was a common 
problem, with the FCT health and human services having no space 
in two sites to build or expand the existing laboratories and 
competing priorities from other projects and programmes. 
Consequently, with the need to implement the project as quickly as 
possible, the procurement of cargo containers was the only option 
available to us. This added, on average, an additional USD 6,792.31 
per site. Studies looking at the cost effectiveness of Xpert in India, 
South Africa and Uganda reported variations in the infrastructure 
cost [3,7,8]. Although the studies did not detail the reasons for 
these differences, they are likely to reflect the national laboratory 
infrastructure and the level of the health system where they are 
placed (tertiary or secondary). 
  
  
Conclusion 
 
Our findings in Abuja demonstrate that countries need to carefully 
consider the placement of Xpert machines based on the quality and 
size of the laboratory infrastructure to ensure that additional 
placement costs are controlled. This echoes the concerns raised at 
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the 2012 fourth Global Laboratory Initiative partners meeting, which 
observed that, although users were pleased with Xpert MTB/ RIF, 
there were concerns about the price of the technology; especially in 
terms of accelerated and sustained roll-out in both low- and middle-
income countries. 
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Table 2: Additional costs of installation of Xpert in laboratories without sufficient space or electricity supply 
  Cost (USD) by Laboratory 
 
Lab 1 Lab 2 Lab 3 
Container 4,743.59 4,743.59 
 
Slabs [to support the container] 102.56 153.85 
 
Sun shield - 224.36 
 
Transportation of container 512.82 173.08 
 
Floor fittings 254.49 237.18 
 
Carpentry 660.90 557.69 
 
Electricity 327.88 368.59 
 
Plumbing 299.68 224.36 
 
Generator 192.31 - 192.31 
Total 7,094.23 7,126.28 192.31 
 
Table 1: Cost of installation of Xpert in laboratories with sufficient space 
  Cost (USD) 
Custom clearance 25.64 
Working bench 102.56 
Chairs 51.28 
Stools 96.15 
Refrigerators 141.03 
Extension cables 19.23 
Printer cable 6.41 
Printer 160.26 
Tables 19.23 
Engraving of equipment 19.23 
Anti-virus 25.64 
Air-conditioners 192.31 
Voltage stabilizer 96.15 
Inverters/Batteries and accessories 1,666.86 
Total 2621.98 
